GlassScriptPhysician profile
Ida Molavi
NPI 1730663907
$5,029.54
in general payments reported to CMS, 2019-2025
13 companies · $3,955 in 2025
The $3,955 reported for 2025 was more than what 85% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $29.13 · 2022: $123 · 2023: $514 · 2024: $284 · 2025: $3,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,402 · Travel and Lodging: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,402.29 |
| Travel and Lodging | $850.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,458.62 | 2025 | |
| Zimmer Biomet Holdings, INC. | $265.71 | 2022-2023 | Advantagerib |
| Polynovo North America LLC | $209.21 | 2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $193.28 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $146.95 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $136.61 | 2024 | Starling System |
| Medtronic, INC. | $132.50 | 2025 | Transorb |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Acell, INC. | $124.46 | 2019 | |
| La Jolla Pharmaceutical Company | $119.13 | 2023 | Giapreza |
| Haemonetics Corporation | $59.41 | 2023 | Teg6s Hemostasis System |
| Ethicon US, LLC | $29.53 | 2025 | Echelon Flex |
| Potrero Medical, INC. | $29.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ida Molavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.